Rhenman & Partners Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,800
Closed -$3.3M 94
2025
Q4
$3.3M Sell
35,800
-25,200
-41% -$2.41M 0.31% 75
2025
Q3
$4.53M Buy
61,000
+30,500
+100% +$3.09M 0.5% 60
2025
Q2
$3.96M Buy
30,500
+14,500
+91% +$2.1M 0.5% 58
2025
Q1
$2.55M Sell
16,000
-134,041
-89% -$24.2M 0.29% 64
2024
Q4
$27.8M Buy
150,041
+28,041
+23% +$5.44M 2.86% 7
2024
Q3
$25.7M Buy
122,000
+105,000
+618% +$18.2M 2.09% 18
2024
Q2
$2.28M Sell
17,000
-25,000
-60% -$4.73M 0.22% 72
2024
Q1
$9.02M Buy
42,000
+24,000
+133% +$4.7M 0.86% 42
2023
Q4
$3.66M Buy
18,000
+11,000
+157% +$1.78M 0.37% 64
2023
Q3
$1.39M Sell
7,000
-8,400
-55% -$2.12M 0.15% 78
2023
Q2
$5M Sell
15,400
-22,992
-60% -$6.57M 0.53% 57
2023
Q1
$9.14M Sell
38,392
-22,608
-37% -$5.71M 1% 34
2022
Q4
$15.4M Sell
61,000
-2,000
-3% -$426K 1.6% 26
2022
Q3
$12.3M Buy
63,000
+13,000
+26% +$2.61M 1.29% 33
2022
Q2
$9.13M Buy
50,000
+2,500
+5% +$499K 1.04% 37
2022
Q1
$12.2M Buy
47,500
+1,127
+2% +$258K 1.2% 34
2021
Q4
$10.7M Buy
+46,373
New +$11.3M 0.71% 50

Other funds holding INSP